Clinical Trial
A Phase 3 Multicenter, Randomized, Double Masked, Sham- Controlled Clinical Trial to Assess the Safety and Efficacy of Intravitreal Administration of Zimura (Complement C5 Inhibitor) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Disease
Disease type
Other
Orphan drug recognition
Yes
Patient type
Adult
Children
Inclusion / Exclusion
Funding
private
Members involved
Others investigators
Dr Laura Mauring
Estonia
Dr Philipp Herrmann
Germany
Pr Martin Spitzer
Germany
Dr Johannes Birtel
Germany
Pr Katarina Stingl
Germany
Dr Susanne KOHL
Germany
Dr Giacomo Maria Bacci
Italy
Pr Francesca Simonelli
Italy
Pr Francesco Testa
Italy
ERN EYE member investigating site
HCP : Principal investigators
Tartu University Hospital, Estonia
Adress
Ludvig Puusepa 8
50406 Tartu
Estonia
Fondation Adolphe de Rothschild, Paris, France
Adress
25-29 Rue Manin
75019 Paris
France
University of Bonn, Germany
Adress
Ernst-Abbe-Strasse 2
53127 Bonn
Germany
Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
Adress
Martinistraße 52
20251 Hamburg
Germany
Klinikum der Universität München, Germany
Adress
Mathildenstraße 8
80336 Munich
Germany
Centre for Ophthalmology, University Eye Hospital, Tübingen, Germany
Adress
Department für Augenheilkunde Tübingen Forschungsinstitut für Augenheilkunde Elfriede-Aulhorn-Str. 7
72076 Tübingen
Germany
Department of Ophthalmology Semmelweis University, Budapest, Hungary
Adress
Mária u. 39
1085 Budapest
Hungary
AOU Careggi – AOU Meyer Consortium, Firenze, Italy
Adress
Largo Brambilla 3
50134 Florence
Italy
AOU Università degli Studi della Campania Luigi Vanvitelli, Napoli, Italy
Adress
Via Santa Maria di Costantinopoli
104, 80138 Napoli NA
Italy
University Hospital Graz, Department of Neuro-Ophthalmology, Graz, Austria
Adress
Auenbruggerplatz 4
8036 Graz
Austria